The Food and Drug Administration is preparing to implement the Drug Quality and Security Act.
In new regs, the administration signaled it is exploring ways to raise payments to insurers that take on more risk.
Letting people keep their insurance means fewer healthy people would buy in exchanges.
23andMe never received FDA clearance to market its DNA test kits.
The embattled agency has a major role in imposing and enforcing dozens of new regulations.
Insurance commissioners in roughly half the states have weighed in on the president's decision to allow people to keep policies that would otherwise have been canceled under the landmark health law.
"We’re probably sitting somewhere between 60 or 70 percent [completed],” an official said.
Republicans said it was troubling that Henry Chao had not read the audit of problems.
Democrats say their GOP colleagues are giving ObamaCare docs to the press before lawmakers.
Healthcare advocates are urging the White House to reject language they say would lock in high prices for biologic drugs.